Beyond Fillers.
The definitive answer
to Ozempic Face.
Semaglutide and tirzepatide have transformed millions of bodies. But rapid fat loss often leaves the face hollow, deflated, and prematurely aged. At the Center of Aesthetic and Reconstructive Surgery, Dr. Kongkrit Chaiyasate restores natural facial harmony through deep-plane facelift and autologous fat grafting — a sophisticated, surgical answer to a sophisticated problem.
When the body wins,
but the face pays.
The advent of GLP-1 receptor agonists — semaglutide1 (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — has revolutionized medical weight management. Clinical trials demonstrate sustained losses of 15 to 17 percent of body weight, accompanied by profound improvements in cardiovascular and metabolic health.
Yet this rapid, dramatic transformation produces a highly visible aesthetic consequence: a constellation of facial changes the public has christened "Ozempic face."2 For many, the triumph of reaching their ideal body weight is overshadowed by a face that looks gaunt, deflated, and disproportionately aged.
Research published in Aesthetic Surgery Journal documents that GLP-1 users experience a median decrease of up to 9 percent in total midfacial volume3 — a degree of structural loss that no skincare regimen, and few non-surgical treatments, can correct.
Three layers of loss,
one prematurely aged face.
The youthful face derives its character from a precise architecture of fat compartments — superficial and deep — supported by a resilient skin envelope. Rapid GLP-1 weight loss collapses all three pillars simultaneously.
Cheek and temple fat — the architecture of the youthful 'heart-shaped' face — depletes first. The result: flattened cheeks, hollow temples, and prominent tear troughs.
The deep medial cheek and buccal compartments empty quickly with rapid systemic fat loss, producing the gaunt, skeletonized look and pronounced nasolabial folds.
Collagen and elastin networks cannot retract fast enough to keep pace with rapid volume loss, leading to lower facial laxity, jowling, and visible neck banding.
You cannot inject
your way out of laxity.
Hyaluronic acid fillers and biostimulators such as Sculptra excel at addressing mild, localized volume deficits. They are, however, fundamentally inadequate for the profound structural collapse of GLP-1-induced facial deflation.
Attempting to correct severe deflation with fillers alone requires massive volumes of product. The result is the unmistakable over-filled, doughy appearance that has come to define poorly executed facial aesthetics.
More importantly, fillers cannot lift sagging skin. They merely inflate the deflated envelope without addressing the underlying tissue architecture. A surgical answer is required.
A dual-modality solution to
a dual-modality problem.
Dr. Chaiyasate approaches GLP-1 facial deflation as a complex architectural collapse — not a simple volume deficit. The gold standard combines structural lifting with autologous volume restoration.
Deep-Plane
Facelift
Unlike traditional facelifts that primarily pull the skin, the deep-plane technique releases the retaining ligaments of the face and repositions the underlying SMAS muscular layer. The result is a vertical, natural elevation that eliminates jowling and neck banding without the "pulled" appearance of older techniques.
Autologous
Fat Grafting
Fat is gently harvested from the abdomen or thighs, purified, and meticulously micro-grafted into the depleted cheek, temple, and periorbital compartments. Because it is your own living tissue, it integrates permanently — providing soft, natural volume that synthetic fillers cannot replicate. Adipose-derived stem cells additionally improve overlying skin quality.
Every face deserves a plan
built only for it.
No two patients on GLP-1 therapy present identically. The degree of volume loss, skin laxity, weight trajectory, and individual aesthetic goals all shape the surgical strategy. Dr. Chaiyasate begins every consultation by listening — then constructs a treatment plan tailored to the unique anatomy and ambitions of the patient before him.
Patients should reach and maintain their target weight for 3–6 months prior to facial rejuvenation surgery.
From mild superficial deflation to severe deep-pad collapse — each presentation calls for a different surgical strategy.
Fitzpatrick type, elasticity, and sun damage influence whether laser resurfacing is added to the surgical plan.
Because most patients remain on maintenance GLP-1 dosing, the volume and lifting plan is built to endure long-term.
Let your face
match your vitality.
You have done the hard work. You have transformed your body and your health. Now allow Dr. Chaiyasate to restore the natural harmony of your face — with the quiet permanence that only autologous tissue and surgical artistry can deliver.